B. Canbakan Et Al. , "The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.," Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week , vol.128, no.4, Chicago, United States Of America, pp.771-772, 2005
Canbakan, B. Et Al. 2005. The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.. Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week , (Chicago, United States Of America), 771-772.
Canbakan, B., ŞENTÜRK, H., TABAK, Ö. F., Akdoğan, M., ÖZARAS, R., Tahan, V., ... MERT, A.(2005). The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial. . Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week (pp.771-772). Chicago, United States Of America
Canbakan, Billur Et Al. "The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.," Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Chicago, United States Of America, 2005
Canbakan, Billur Et Al. "The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.." Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week , Chicago, United States Of America, pp.771-772, 2005
Canbakan, B. Et Al. (2005) . "The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.." Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week , Chicago, United States Of America, pp.771-772.
@conferencepaper{conferencepaper, author={Billur Canbakan Et Al. }, title={The efficacy of IFN alfa-2b, and lamivudine combination treatment in comparison to IFN alfa-2b alone in chronic delta hepatitis: a randomized trial.}, congress name={Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week}, city={Chicago}, country={United States Of America}, year={2005}, pages={771-772} }